These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 39160538

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. EZH2 mutations are related to low blast percentage in bone marrow and -7/del(7q) in de novo acute myeloid leukemia.
    Wang X, Dai H, Wang Q, Wang Q, Xu Y, Wang Y, Sun A, Ruan J, Chen S, Wu D.
    PLoS One; 2013; 8(4):e61341. PubMed ID: 23613835
    [Abstract] [Full Text] [Related]

  • 25. Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients.
    Stomper J, Meier R, Ma T, Pfeifer D, Ihorst G, Blagitko-Dorfs N, Greve G, Zimmer D, Platzbecker U, Hagemeijer A, Schmitt-Graeff I, Lübbert M.
    Clin Epigenetics; 2021 Apr 12; 13(1):77. PubMed ID: 33845873
    [Abstract] [Full Text] [Related]

  • 26. [Genetic defects of chromosome 5q and 7q in myeloid neoplasms].
    Hosono N.
    Rinsho Ketsueki; 2019 Apr 12; 60(7):800-809. PubMed ID: 31391370
    [Abstract] [Full Text] [Related]

  • 27. TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution.
    Hou HA, Chou WC, Kuo YY, Liu CY, Lin LI, Tseng MH, Chiang YC, Liu MC, Liu CW, Tang JL, Yao M, Li CC, Huang SY, Ko BS, Hsu SC, Chen CY, Lin CT, Wu SJ, Tsay W, Chen YC, Tien HF.
    Blood Cancer J; 2015 Jul 31; 5(7):e331. PubMed ID: 26230955
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation.
    Yoshizato T, Nannya Y, Atsuta Y, Shiozawa Y, Iijima-Yamashita Y, Yoshida K, Shiraishi Y, Suzuki H, Nagata Y, Sato Y, Kakiuchi N, Matsuo K, Onizuka M, Kataoka K, Chiba K, Tanaka H, Ueno H, Nakagawa MM, Przychodzen B, Haferlach C, Kern W, Aoki K, Itonaga H, Kanda Y, Sekeres MA, Maciejewski JP, Haferlach T, Miyazaki Y, Horibe K, Sanada M, Miyano S, Makishima H, Ogawa S.
    Blood; 2017 Apr 27; 129(17):2347-2358. PubMed ID: 28223278
    [Abstract] [Full Text] [Related]

  • 30. Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms.
    Patel SS, Ho C, Ptashkin RN, Sadigh S, Bagg A, Geyer JT, Xu ML, Prebet T, Mason EF, Seegmiller AC, Morgan EA, Steensma DP, Winer ES, Wong WJ, Hasserjian RP, Weinberg OK.
    Blood Adv; 2019 May 14; 3(9):1540-1545. PubMed ID: 31085507
    [Abstract] [Full Text] [Related]

  • 31. TP53 copy number and protein expression inform mutation status across risk categories in acute myeloid leukemia.
    Tashakori M, Kadia T, Loghavi S, Daver N, Kanagal-Shamanna R, Pierce S, Sui D, Wei P, Khodakarami F, Tang Z, Routbort M, Bivins CA, Jabbour EJ, Medeiros LJ, Bhalla K, Kantarjian HM, Ravandi F, Khoury JD.
    Blood; 2022 Jul 07; 140(1):58-72. PubMed ID: 35390143
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China.
    Yang J, Zhao L, Wu Y, Niu T, Gong Y, Chen X, Huang X, Liu J, Dai Y, Ma H.
    Cancer Med; 2023 Dec 07; 12(23):21111-21117. PubMed ID: 37937729
    [Abstract] [Full Text] [Related]

  • 37. High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome.
    Krauth MT, Eder C, Alpermann T, Bacher U, Nadarajah N, Kern W, Haferlach C, Haferlach T, Schnittger S.
    Leukemia; 2014 Jul 07; 28(7):1449-58. PubMed ID: 24402164
    [Abstract] [Full Text] [Related]

  • 38. The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation.
    Poiré X, Labopin M, Polge E, Volin L, Finke J, Ganser A, Blaise D, Yakoub-Agha I, Beelen D, Forcade E, Lioure B, Socié G, Niederwieser D, Labussière-Wallet H, Maertens J, Cornelissen J, Craddock C, Mohty M, Esteve J, Nagler A.
    Am J Hematol; 2020 Mar 07; 95(3):282-294. PubMed ID: 31876307
    [Abstract] [Full Text] [Related]

  • 39. TP53 mutations and MDM2(SNP309) identify subgroups of AML patients with impaired outcome.
    Falk IJ, Willander K, Chaireti R, Lund J, Nahi H, Hermanson M, Gréen H, Lotfi K, Söderkvist P.
    Eur J Haematol; 2015 Apr 07; 94(4):355-62. PubMed ID: 25156865
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.